Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.40 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14881144 | 0.81 | KCNN4 (0.50) | CES1KCNN4MAPTKMT2ACYP2C19 | |
| SCHEMBL340836 | 0.79 | KCNN4 (0.52) | CES1KCNN4MAPTKMT2ACYP2C19 | |
| Hydrochloric Acid SCHEMBL8044029 | 0.78 | KCNN4 (0.50) | CES1KCNN4MAPTKMT2ACYP2C19 | |
| SCHEMBL14062648 | 0.78 | CES1 (0.50) | CES1KCNN4MAPTKMT2ACYP2C19 | |
| Ammonia Solution, Strong SCHEMBL9292403 | 0.78 | KCNN4 (0.50) | CES1KCNN4MAPTKMT2ACYP2C19 | |
| SCHEMBL342555 | 0.76 | KCNN4 (0.64) | CES1KCNN4MAPTKMT2ACYP2C19 | |
| SCHEMBL3905516 | 0.76 | MAPT (0.55) | CES1KCNN4MAPTKMT2ACYP2C19 | |
| SCHEMBL28392840 | 0.76 | CES1 (0.48) | CES1KCNN4MAPTKMT2ACYP2C19 | |
| Water SCHEMBL9292645 | 0.76 | CES1 (0.48) | CES1KCNN4MAPTKMT2ACYP2C19 | |
| SCHEMBL9292108 | 0.76 | KCNN4 (0.48) | CES1KCNN4MAPTKMT2ACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1582201-B1 | Use of asymmetrically substituted triazine derivatives for solubilising or for enhancing the solubilisation of symmetrically substituted triazine derivatives in oil compositions | BEIERSDORF AG (DE) | 2013-08-21 | — | — | EP | disclosed |
| EP-1582201-A2 | Use of asymmetrically substituted triazine derivatives for solubilising or for enhancing the solubilisation of symmetrically substituted triazine derivatives in oil compositions | Beiersdorf AG (DE) | 2005-10-05 | — | — | EP | disclosed |
| EP-1559413-A2 | Stable cosmetic or dermatologic compositions in the form of W/O emulsions containing asymmetrically substituted triazine derivatives | Beiersdorf AG (DE) | 2005-08-03 | — | — | EP | disclosed |
| EP-0950397-B1 | Use of asymmetrically substituted triazine derivatives for solubilising or for enhancing the solubilizing of symmetrically substituted triazine derivatives | BEIERSDORF AG (DE) | 2005-07-27 | — | — | EP | disclosed |
| EP-1071394-B1 | USE OF UNSYMMETRICALLY SUBSTITUTED TRIAZINE DERIVATIVES IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR MAINTAINING THE UROCANIC ACID STATUS OF THE SKIN | BEIERSDORF AG (DE) | 2004-07-14 | — | — | EP | disclosed |
| EP-0950397-A1 | Use of asymmetrically substituted triazine derivatives for solubilising or for enhancing the solubilizing of symmetrically substituted triazine derivatives | Beiersdorf Aktiengesellschaft (DE) | 1999-10-20 | — | — | EP | disclosed |
| EP-0950396-A1 | Stable cosmetic or dermatologic compositions in the form of W/O emulsions containing asymmetrically substituted triazine derivatives | Beiersdorf Aktiengesellschaft (DE) | 1999-10-20 | — | — | EP | disclosed |